Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study

1. Deodhar, A.
2. Gottlieb, A.B.
3. Boehncke, W.-H.
4. Dong, B.
5. Wang, Y.
6. Zhuang, Y.
7. Barchuk, W.
8. Xu, X.L.
9. Hsia, E.C.
10. AELION, J.
11. AMARELO-RAMOS, J.
12. BALSA, A.
13. BERGHEA, F.
14. BRZEZICKI, J.
15. BURNETTE, M.
16. FRETZIN, S.
17. GARCÍA-CARAZO, S.
18. GLADSTEIN, G.
19. GOMEZ-REINO, J.
20. GOODERHAM, M.
21. GONZÁLEZ-FERNÁNDEZ, C.
22. GOTTLIEB, A.
23. GRATACOS, J.
24. HAALAND, D.
25. KAMALOVA, R.
26. LESZCZYNSKI, P.
27. MARTIN-MOLA, E.
28. MASLYANSKY, A.
29. NAVARRO, F.
30. OPRIS, D.
31. PAPP, K.
32. PERLAMUTROV, Y.
33. PHILIPP, S.
34. RACEWICZ, A.
35. REBROV, A.
36. RELL-BAKALARSKA, M.
37. ROSMARIN, D.
38. RUBBERT-ROTH, A.
39. SHERGY, W.
40. SHIRINSKY, I.
41. SONIN, D.
42. STANISLAV, M.
43. SUKHAREV, A.
44. TEMNIKOV, V.
45. VINOGRADOVA, I.
46. WAYTZ, P.
47. YAKUSHEVICH, V.
48. Mostrar todos los/as autores/as +